Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
525.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (0.765%)
Market Cap: £302.10m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

AGM Statement

25 May 2022 07:00

RNS Number : 6794M
Mortgage Advice Bureau (Hldgs) PLC
25 May 2022
 

25 May 2022

Mortgage Advice Bureau (Holdings) plc ("MAB" or "the Group")

AGM Statement

Mortgage Advice Bureau (Holdings) plc (AIM:MAB1.L) will hold its Annual General Meeting at 2pm today during which the Non-Executive Chair, Katherine Innes Ker, will make the following statement:

"Adviser numbers have continued to grow since our final results statement on 28 March 2022 and had risen to 2,0461 advisers by 20 May 2022, an increase of 9% year to date. Our current pipeline of incoming new Appointed Representatives and advisers is also strong, as is our pipeline of written new business that will go on to complete over the coming months. In addition, we continue to grow the number of new customer leads into MAB, which will help the Group to deliver further market share growth. This all reflects the strong momentum that the Group has built and will support MAB's plans to deliver secure and sustained profitable growth.

"MAB's mortgage completions for Q1 2022 were £5.8bn, representing an increase of 11% on a notably strong Q1 2021 (which in no small part was driven by stamp duty relief) and 44% on Q1 2020. We are pleased with this performance, especially when compared to the exceptional market performance we saw in the first half of 2021.

"Despite the geopolitical uncertainty and the rising cost of living for UK households, those that want or need to move home continue to do so. Consumer demand for housing remains high and activity is strong. As expected, increases in interest rates have stimulated more refinancing activity, with mortgage borrowers now more motivated than ever to secure the best rate possible to help their household budgeting.

"The resilience shown by people who continue to move home is helped by the fact that employment is high, household savings are high and for those who are subsequent movers, housing equity levels have also risen over recent years. Although interest rates have risen and will most likely continue to rise over the next 12 months, current interest rates remain near historical lows. Lenders also have strong liquidity levels, meaning mortgage availability is now close to pre-pandemic highs, thereby helping the market to remain buoyant.

"As we look out to the second half of the year, we expect to complete our acquisition of Fluent, which is subject to FCA approval of change in control. This acquisition will be transformational for our national lead generation strategy, allowing us to leverage the combined strength of both businesses to attract more new leads into the Group. We also expect the acquisition to be significantly earnings enhancing in the first full year following completion. This, together with our maturing and new growth drivers, will position the enlarged Group to further accelerate its pace of growth. Current trading remains in line with the Board's expectations."

1 Includes a total of 72 advisers who are either directly authorised or later life advisers. The directly authorised advisers are employees of a firm previously authorised under an Appointed Representative agreement with MAB until 7 December 2020. MAB continues to provide services to this firm, which is now directly authorised by the FCA. For both later life and directly authorised advisers the fees received by MAB represent the net income received by MAB as there are no commission payouts made by MAB. Also includes 14 advisers from associates, who are in the process of being onboarded under MAB's AR arrangements. These advisers will shortly become mainstream advisers. Until these 14 advisers become onboarded fully as mainstream advisers, MAB currently only recognises its share of profit after tax from these associates.

 

Enquiries:

Mortgage Advice Bureau (Holdings) plc  +44 (0)1332 525007

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Deputy Chief Executive Officer

Lucy Tilley, Chief Financial Officer

Nominated Adviser and Broker: 

Numis Securities Limited Tel: +44 (0)20 7260 1000

Stephen Westgate / Giles Rolls

Media Enquiries: 

investorrelations@mab.org.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMSEDFALEESESI
Date   Source Headline
1st May 20247:00 amRNSNotification of Major Holdings
30th Apr 20242:21 pmRNSDirectors' Shareholdings and PDMR notification
25th Apr 20244:40 pmRNSNotice of Results and AGM
23rd Apr 20244:27 pmRNSGrant of Options and Total Voting Rights
23rd Apr 20247:00 amRNSBoard Changes
17th Apr 20244:57 pmRNSPDMR dealing
15th Apr 20246:09 pmRNSDirector/PDMR Shareholding
28th Mar 20244:01 pmRNSDirectors' Shareholdings and PDMR notification
19th Mar 20247:00 amRNSFinal Results for the year ended 31 December 2023
15th Mar 20247:00 amRNSDirectors' Shareholdings and PDMR notification
8th Mar 202411:41 amRNSNotification of Major Holdings
29th Feb 20243:21 pmRNSDirectors' Shareholdings and PDMR notification
23rd Feb 20243:25 pmRNSNotification of Major Holdings
19th Feb 20246:17 pmRNSNotification of Major Holdings
19th Feb 20246:15 pmRNSNotification of Major Holdings
14th Feb 20244:09 pmRNSDirectors' Shareholdings and PDMR notification
9th Feb 20247:00 amRNSNotification of Major Holdings
6th Feb 20243:15 pmRNSNotification of Major Holdings
31st Jan 20243:38 pmRNSDirectors' Shareholdings and PDMR notification
26th Jan 20247:00 amRNSNotification of Major Holdings
25th Jan 20247:00 amRNSTrading Update
15th Jan 20243:15 pmRNSDirectors' Shareholdings and PDMR notification
15th Jan 20247:00 amRNSBoard Change
12th Jan 20241:43 pmRNSBlock listing Interim Review
29th Dec 202311:03 amRNSDirectors' Shareholdings and PDMR notification
15th Dec 202310:26 amRNSDirectors' Shareholdings and PDMR notification
30th Nov 20235:57 pmRNSDirectors' Shareholdings and PDMR notification
21st Nov 202311:49 amRNSNotification of Major Holdings
14th Nov 20234:29 pmRNSDirectors' Shareholdings and PDMR notification
3rd Nov 20233:43 pmRNSDirector/PDMR Shareholding
31st Oct 20234:00 pmRNSDirectors' Shareholdings and PDMR notification
16th Oct 20235:07 pmRNSDirectors' Shareholdings and PDMR notification
12th Oct 202311:10 amRNSNotification of Major Interest in Shares
10th Oct 20231:32 pmRNSNotification of Major Interests in Shares
9th Oct 20235:55 pmRNSNotification of Major Interests in Shares
28th Sep 202312:11 pmRNSNotification of Major Holdings
26th Sep 20237:00 amRNSInterim Results
18th Sep 20232:40 pmRNSDirectors' Shareholdings and PDMR notification
31st Aug 20234:43 pmRNSDirectors' Shareholdings and PDMR notification
14th Aug 20233:24 pmRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSStandard form for notification of major holdings
1st Aug 202311:23 amRNSDirector/PDMR Shareholding
26th Jul 20237:00 amRNSTrading Update
21st Jul 20232:59 pmRNSNotification of major holdings
18th Jul 20235:34 pmRNSDirectors' Shareholdings and PDMR notification
17th Jul 202312:43 pmRNSDirectors' Shareholdings and PDMR notification
13th Jul 20235:03 pmRNSBlock listing Interim Review
11th Jul 20237:00 amRNSDirectors' Shareholdings and PDMR notification
30th Jun 202312:08 pmRNSDirector/PDMR Shareholding
16th Jun 202311:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.